|
National Stock Number(NSN): 6505-01-166-9018 (6505011669018, 011669018)
| NIIN: |
01-166-9018 |
Item Name: |
THEOPHYLLINE EXTENDED-RELEASE CAPSULES |
INC: |
42774
|
| FSC: |
6505
|
Assignment Date: |
Nov-18-1983 |
CRIT: |
X |
IIG: |
42774 |
| ISC: |
5 |
Date Standardized: |
Nov-18-1983 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9285 |
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00067-0100-68 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
C |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
|
NDC00075-0100-00 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
C |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
SLO-BID |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
SLO-BID GYROCAP |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
7-0498 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
Q |
U |
1 |
A |
$6.86 |
BT |
|
C2201X- |
Mar-01-2003 |
H |
| DF |
|
Y |
|
|
|
|
F |
$0.00 |
BT |
|
------- |
Jan-01-2003 |
H |
| DN |
S9M |
Y |
|
Q |
U |
1 |
N |
$6.86 |
BT |
|
9L----- |
Dec-01-2002 |
H |
| DS |
S9M |
H |
|
Q |
U |
1 |
D |
$6.86 |
BT |
|
------- |
Oct-01-2002 |
H |
| VA |
JVS |
I |
|
M |
U |
0 |
V |
$0.00 |
BT |
|
------- |
Apr-01-1989 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 100 TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
THEOPHYLLINE CAPSULES MODIFIED 100MG 100S BT |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| FEAT |
SPECIAL FEATURES |
ANHYDROUS |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| THPE |
THERAPEUTIC EQUIVALENT |
SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|